TY - JOUR
T1 - Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.
AU - Yap, Joanne
AU - Salamonsen, Lois A
AU - Jobling, Tom
AU - Nicholls, Peter
AU - Dimitriadis, Evdokia
PY - 2010
Y1 - 2010
N2 - Abstract
Background: Interleukin (IL) 11 is produced by human endometrium and endometrial cancer tissue. It has roles in
endometrial epithelial cell adhesion and trophoblast cell invasion, two important processes in cancer progression. This
study aimed to determine the levels of IL11 in uterine lavage fluid in women with endometrial cancer and
postmenopausal women. It further aimed to determine the levels of IL11 protein and its signaling molecules in human
endometrial cancer of varying grades, and endometrium from postmenopausal women and IL11 signalling
mechanisms in endometrial cancer cell lines.
Methods: IL11 levels in uterine lavage were measured by ELISA. IL11, IL11 receptor(R) I?, phosphorylated (p) STAT3 and
SOCS3 were examined by immunohistochemistry in endometrial carcinomas and in control endometrium from
postmenopausal women and normal cycling women. The effect of IL11 on pSTAT3/STAT3 and SOCS3 protein
abundance in endometrial cancer cell lines and non-cancer endometrial epithelial cells was determined by Western
blot.
Results: IL11 was present in uterine flushings and was significantly higher in women with Grade 1 carcinomas
compared to postmenopausal women (p <0.05). IL11 immunostaining was significantly elevated in the endometrial
tumour epithelial cells from Grade 1 and 3 compared to endometrial epithelium from postmenopausal and cycling
women. IL11RI? immunostaining intensity was increased in cancer epithelium in the Grades 1 and 2 tumours
compared to epithelium from postmenopausal women. Both IL11 and IL11RI? localized to vascular endothelial and
smooth muscle cells while IL11 also localized to subsets of leucocytes in the cancer tissues. pSTAT3 was found in both
the tumour epithelial and stromal compartments but was maximal in the tumour epithelial cells, while SOCS3 was
predominantly found in the tumour epithelial cells. pSTAT3 staining intensity was significantly higher in Grade 1 and 2
tumour epithelial cells compared to epithelial cells from cycling and postmenopausal women. SOCS3 staining intensity
did not differ between between each tumour and postmenopausal endometrial epithelium but SOCS3 in cycling
endometrium was significantly higher compared to postmonopausal and Tumour Grades 2 and 3. IL11 increased
pSTAT3/STAT3 in all tumour cell lines, while SOCS3 abundance was increased only in one tumour cell line.
Conclusions: The present study suggests that IL11 in uterine washings may be useful as a diagnostic marker for early
stage endometrial cancer. It indicates that IL11, along with its specific receptor, IL11RI?, and downstream signalling
molecules, STAT3 and SOCS3, are likely to play a role in the progression of endometrial carcinoma. The precise role of
IL11 in endometrial cancer remains to be elucidated.
AB - Abstract
Background: Interleukin (IL) 11 is produced by human endometrium and endometrial cancer tissue. It has roles in
endometrial epithelial cell adhesion and trophoblast cell invasion, two important processes in cancer progression. This
study aimed to determine the levels of IL11 in uterine lavage fluid in women with endometrial cancer and
postmenopausal women. It further aimed to determine the levels of IL11 protein and its signaling molecules in human
endometrial cancer of varying grades, and endometrium from postmenopausal women and IL11 signalling
mechanisms in endometrial cancer cell lines.
Methods: IL11 levels in uterine lavage were measured by ELISA. IL11, IL11 receptor(R) I?, phosphorylated (p) STAT3 and
SOCS3 were examined by immunohistochemistry in endometrial carcinomas and in control endometrium from
postmenopausal women and normal cycling women. The effect of IL11 on pSTAT3/STAT3 and SOCS3 protein
abundance in endometrial cancer cell lines and non-cancer endometrial epithelial cells was determined by Western
blot.
Results: IL11 was present in uterine flushings and was significantly higher in women with Grade 1 carcinomas
compared to postmenopausal women (p <0.05). IL11 immunostaining was significantly elevated in the endometrial
tumour epithelial cells from Grade 1 and 3 compared to endometrial epithelium from postmenopausal and cycling
women. IL11RI? immunostaining intensity was increased in cancer epithelium in the Grades 1 and 2 tumours
compared to epithelium from postmenopausal women. Both IL11 and IL11RI? localized to vascular endothelial and
smooth muscle cells while IL11 also localized to subsets of leucocytes in the cancer tissues. pSTAT3 was found in both
the tumour epithelial and stromal compartments but was maximal in the tumour epithelial cells, while SOCS3 was
predominantly found in the tumour epithelial cells. pSTAT3 staining intensity was significantly higher in Grade 1 and 2
tumour epithelial cells compared to epithelial cells from cycling and postmenopausal women. SOCS3 staining intensity
did not differ between between each tumour and postmenopausal endometrial epithelium but SOCS3 in cycling
endometrium was significantly higher compared to postmonopausal and Tumour Grades 2 and 3. IL11 increased
pSTAT3/STAT3 in all tumour cell lines, while SOCS3 abundance was increased only in one tumour cell line.
Conclusions: The present study suggests that IL11 in uterine washings may be useful as a diagnostic marker for early
stage endometrial cancer. It indicates that IL11, along with its specific receptor, IL11RI?, and downstream signalling
molecules, STAT3 and SOCS3, are likely to play a role in the progression of endometrial carcinoma. The precise role of
IL11 in endometrial cancer remains to be elucidated.
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901310/pdf/1477-7827-8-63.pdf
U2 - 10.1186/1477-7827-8-63
DO - 10.1186/1477-7827-8-63
M3 - Article
VL - 8
SP - 63
EP - 73
JO - Reproductive Biology and Endocrinology
JF - Reproductive Biology and Endocrinology
SN - 1477-7827
ER -